未登录

杨

杨慧 (Hui Yang)

Central South University

H指数:24

被引数:4,091

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FGF21 Blunts Cardiac Ischemia/Reperfusion Injury by Promoting Autophagic Flux Via Stat1/Irgm1 Pathway

FGF21通过促进Stat1/Irgm1通路介导的自噬流来减轻心肌缺血/再灌注损伤。

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH

IF2.5

2025-10-010

PRE

Melatonin alleviates cholestatic liver injury through modulating gut microbiota and activating the NRF2/HO-1 antioxidant pathway

褪黑素通过调节肠道微生物群和激活NRF2/HO-1抗氧化通路来缓解胆汁淤积性肝损伤。

Tissue and Cell

IF2.5

2025-09-060

PRE

Predicting Thoracolumbar Vertebral Osteoporotic Fractures: Value Assessment of Chest CT-Based Machine Learning

预测胸腰椎骨质疏松性骨折：基于胸部CT的机器学习价值评估

Academic Radiology

IF3.9

2025-07-100

OAAI

Efficacy and Safety of Simnotrelvir-Ritonavir Compared With Nirmatrelvir-Ritonavir in the Treatment of COVID-19: Real-World Evidence From a Retrospective Cohort Study During the Prevalence of the Omicron EG.5 Variant

沙莫特雷韦-利托那韦与奈玛特雷韦-利托那韦治疗COVID-19的疗效与安全性比较：奥密克戎EG.5变异株流行期间一项回顾性队列研究的真实世界证据

Clinical Therapeutics

IF3.6

2025-07-030

PRE

Effects of quantitative marinating on meat quality, biogenic amines, and flavor compounds in crayfish meat

定量腌制对小龙虾肉品质、生物胺和风味化合物的影响

FRONTIERS IN NUTRITION

IF5.1

2025-04-100

OA

Lactococcus garvieae aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2025-03-140

PRE

Inappropriate Prescribing of Nirmatrelvir/Ritonavir in Solid Organ Transplantation With COVID-19 Infection: A Multicenter Retrospective Study

CLINICAL THERAPEUTICS

IF3.6

2025-01-010

PRE

Skin cancer associated with calcineurin inhibitors treatment: analysis of FAERS database

EXPERT OPINION ON DRUG SAFETY

IF3.1

2024-12-250

PRE

Catatonia related to tacrolimus: a real world pharmacovigilance study of FDA adverse event reporting system (FAERS) database

与他克莫司相关的紧张症: FDA不良事件报告系统 (FAERS) 数据库的真实世界药物警戒研究

EXPERT OPINION ON DRUG SAFETY

IF3.1

2024-08-210

PRE

Tacrolimus related diabetic ketoacidosis and hyperglycaemic hyperosmolar nonketotic syndrome: an observational, retrospective, pharmacovigilance study

EXPERT OPINION ON DRUG SAFETY

IF3.1

2024-08-190

PRE

Immune checkpoint inhibitor related myositis: an observational, retrospective, pharmacovigilance study

EXPERT OPINION ON DRUG SAFETY

IF3.1

2024-04-242

PRE

Effectiveness and safety of nirmatrelvir-ritonavir in kidney transplant recipients with severe kidney dysfunction infected with COVID-19

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2024-03-062

OA

Urinary tract infection following the use of BTK inhibitors: a real-world analysis of post-marketing surveillance data

EXPERT OPINION ON DRUG SAFETY

IF3.1

2023-08-251

PRE

Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-06-263

OAAI

Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting System

CLINICAL THERAPEUTICS

IF3.6

2023-02-015

PRE

Patients' Willingness of First Visit in Primary Medical Institutions and Policy Implications: A National Cross-Sectional Survey in China

FRONTIERS IN PUBLIC HEALTH

IF3.4

2022-04-019

OAAI

Cutaneous Toxicity Associated With Enfortumab Vedotin: A Real-Word Study Leveraging US Food and Drug Administration Adverse Event Reporting System

FRONTIERS IN ONCOLOGY

IF3.3

2022-01-1917

OAAI

A Cross-Sectional Study on Mental Health Problems of Medical and Nonmedical Students in Shandong During the COVID-19 Epidemic Recovery Period

FRONTIERS IN PSYCHIATRY

IF3.2

2021-06-1118

OAAI

Intercellular Adhesion Molecule-1 as Target for CAR-T-Cell Therapy of Triple-Negative Breast Cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-09-2339

OAAI

Association Between the Overall Risk of Prostate Cancer and Use of Calcium Channel Blockers: A Systematic Review and Meta-analysis

CLINICAL THERAPEUTICS

IF3.6

2020-09-0114

PREAI

研究方向

团队在多个前沿领域深耕不辍，研究方向涵盖咽喉及嗓音疾病头颈肿瘤基础研究头颈肿瘤临床应用再生医学生物材料免疫治疗分子机制研究人工智能技术咽喉嗓音疾病的临床标准化研究咽喉嗓音疾病诊疗流程和评价标准发病机制病程进展治疗方案优化及疗效评估，力求提供规范化标准化诊疗路径新型嗓音保护与康复技术咽喉嗓音疾病精准化治疗人工智能技术在嗓音分析和喉镜图片中的应用AI驱动的数据处理生物学机制分析疾病早筛及预后评估无创疾病检测和预警体系组织工程与生物材料创新应用声带损伤等方面的应用，关注材料的生物相容性力学性能及降解性等，为咽喉组织再生头颈肿瘤免疫机制与创新治疗嗓音疾病模型早期诊断头颈肿瘤发生发展分子机制研究ATAC-Seq多组学技术头颈肿瘤发生发展分子机制染色质外环状DNA染色质基因表达和细胞命运癌细胞的异常增殖与侵袭行为的机制肿瘤微环境中ecDNA的形成表观遗传修饰肿瘤进展的潜在靶点精准靶向治疗新型免疫疗法肿瘤力学在喉部疾病中的研究迁移声带振动对喉部疾病的影响机制喉癌的早期干预和创新治疗策略

H 指数:18论文数:104被引数:1,215

H 指数:47论文数:432被引数:2.6万

H 指数:45论文数:229被引数:7,967

H 指数:30论文数:109被引数:9,299

H 指数:29论文数:95被引数:2,512

H 指数:31论文数:129被引数:3,146

H 指数:14论文数:47被引数:1,188

H 指数:18论文数:95被引数:1,101

H 指数:52论文数:275被引数:8,408

H 指数:8论文数:52被引数:293